PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

PRO DEX INC

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 3, 2026

$57.70−0.56 (-0.96%)

Close on Oct 19, 2026

Market cap: $193.98M
P/E (TTM): 14.0
Dividend yield: –

PRO DEX INC income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-06-30	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30	FY 2020 2020-06-30	FY 2019 2019-06-30	FY 2018 2018-06-30	FY 2017 2017-06-30	FY 2016 2016-06-30	FY 2015 2015-06-30	FY 2014 2014-06-30	FY 2013 2013-06-30	FY 2012 2012-06-30	FY 2011 2011-06-30
Revenue	78	67	54	46	42	38	35	27	22	22	19	13	11	12	6.71	24
Cost of Revenue	53	47	39	33	29	24	22	17	15	15	14	9.68	7.85	8.53	12	14
Gross Profit	24	20	15	13	13	14	13	9.78	7.94	7.19	4.92	3.70	2.97	3.72	5.42	10
Research & Development	3.35	3.64	3.19	2.80	2.98	4.38	2.32	1.88	1.89	1.23	1.20	1.67	1.48	1.79	2.07	1.89
Selling, General & Admin	8.00	5.19	–	–	–	–	–	–	–	–	–	–	–	–	–	–
General & Administrative	–	4.84	4.07	4.03	4.90	4.08	3.19	2.49	2.29	2.53	1.88	1.96	1.71	2.57	3.18	3.17
Advertising Expenses	0.00	0.09	0.01	0.00	0.00	0.00	0.00	0.00	0.04	0.00	0.00	0.05	0.06	0.14	0.36	0.40
Operating Expenses	11	8.82	7.38	6.99	8.01	9.05	6.08	4.78	5.55	4.45	4.11	4.61	3.78	5.61	6.78	6.66
Operating Income	13	11	7.17	5.76	5.12	4.53	7.07	5.00	2.39	2.74	0.81	-0.90	-0.81	-1.90	-1.37	3.48
Interest Expense	0.81	0.83	0.56	0.53	0.46	0.35	0.24	0.22	0.01	0.01	0.04	0.01	0.01	0.01	-0.04	-0.15
Interest & Investment Income	0.18	0.08	0.14	0.29	0.08	0.13	0.10	0.27	0.23	0.03	–	0.01	0.01	–	–	–
Income from Equity Investments	–	–	–	–	0.06	–	–	–	–	–	–	–	–	–	–	–
Other Non-Operating Income	5.02	1.37	-4.54	3.67	0.57	3.09	0.84	0.45	0.22	0.02	0.32	0.46	0.06	-0.01	-0.04	0.15
Asset Impairment Charges	–	–	–	–	0.08	–	–	–	1.03	0.11	–	–	–	–	–	–
Gain (Loss) on Investments	5.66	2.12	–	–	0.03	1.33	0.03	0.36	–	–	–	0.46	0.07	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	-0.04	–	0.01	0.01	0.02	0.00	0.02	0.00	-0.01	–	–	–
Pretax Income	18	12	2.63	9.43	5.69	7.62	7.90	5.45	2.61	2.75	1.13	-0.45	-0.76	-1.90	-1.40	3.33
Income Tax Expense	4.35	3.08	0.51	2.35	1.12	1.45	1.79	1.30	0.99	-2.09	0.03	-0.04	-0.10	-0.04	-0.44	0.53
Income from Continuing Operations	–	–	–	–	–	–	–	–	1.62	4.84	1.10	-0.40	-0.65	-1.86	-0.96	2.80
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	0.24	-0.28	0.04	0.16	0.08	0.08	-0.16
Net Income incl. Noncontrolling Interests	0	0.16	0.12	0.11	0	0.07	0.37	–	–	–	–	–	–	–	–	–
Net Income	14	8.98	2.13	7.07	4.57	6.17	6.11	4.15	1.62	5.08	0.82	-0.37	-0.49	-1.78	-0.88	2.64
EPS (Basic)(per share)	4.24	2.73	0.61	1.98	1.26	1.63	1.56	0.99	0.38	1.26	0.20	-0.09	-0.14	-0.54	-0.27	0.81
EPS (Diluted)(per share)	4.12	2.67	0.60	1.95	1.21	1.57	1.50	0.97	0.37	1.25	0.20	-0.09	-0.14	-0.54	-0.27	0.80
Shares Outstanding (Basic, Weighted)(shares)	3.23	3.29	3.50	3.57	3.64	3.80	3.91	4.19	4.30	4.04	4.14	4.17	3.49	3.32	3.27	3.26
Shares Outstanding (Diluted, Weighted)(shares)	3.32	3.36	3.57	3.64	3.76	3.94	4.08	4.30	4.34	4.08	4.17	4.17	3.49	3.32	3.27	3.29
EBITDA	14	12	8.33	6.62	5.85	5.21	7.64	5.44	2.95	3.29	1.42	-0.32	-0.29	-1.31	-0.72	4.18

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 31.4%
Operating margin: 16.8%
Net margin: 17.6%
Return on equity, FY2026: 32.4%

Financial strength

Current ratio: 4.10
Debt to equity: 0.28
Debt to assets: 17.8%
Cash to current liabilities: 63.1%

Valuation

P/E ratio: 14.0
Price to sales: 2.50
Price to book: 4.07
Dividend yield: –